Online citations, reference lists, and bibliographies.
← Back to Search

Severe And Fatal Complications After Diagnostic And Therapeutic ERCP: A Prospective Series Of Claims To Insurance Covering Public Hospitals.

R. Trap, S. Adamsen, O. Hart-Hansen, M. Henriksen
Published 1999 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND AND STUDY AIMS Increasing numbers of patients are undergoing endoscopic retrograde cholangiopancreatography (ERCP) prior to laparoscopic cholecystectomy, and more departments and doctors are performing ERCP, while new data from large prospective series have documented the risks of both diagnostic and therapeutic ERCP. The establishment in Denmark of a Patient Insurance Association, which has covered injury caused during investigation and treatment in public hospitals since July 1992, has made it possible to collect and analyze a large prospective series of ERCP complications for which compensation has been claimed. PATIENTS AND METHODS Thirty-nine consecutive claims for compensation due to complications after ERCP occurring between 1 July 1992 and 31 December 1996 were investigated. Case notes were reviewed, along with laboratory reports and radiographs. The complications were classified according to the international consensus. RESULTS Claims for compensation were made in 39 cases from 25 hospitals. The indication for ERCP was appropriate in 31. Precut papillotomy for access had been performed in seven. The severity of the complications was mild in one patient, moderate in three patients, severe in 24, and fatal in nine; in two cases, the severity was not classifiable. The complications were: pancreatitis in 23 patients (seven cases fatal, one of which had involved a precut procedure), bleeding in two, perforation in nine (six had a precut procedure, one died), and other reasons in five (including one fatal case). Among the nine fatal cases, cannulation had not been achieved in two and the endoscopic retrograde cholangiogram was normal in four, one of whom underwent a sphincterotomy. One patient with a previous adenoma had an endoprosthesis removed, developed gangrenous cholecystitis afterward, and died. Thirty patients were eligible for compensation. The rejected cases included mild and moderate pancreatitis, a case of fatal hemorrhagic pancreatitis in which the patient had refused blood transfusion, and one patient who had pancreatitis prior to ERCP. CONCLUSIONS ERCP, even for diagnostic purposes, may be associated with very serious and even fatal complications. The use of the precut procedure for access should still be considered dangerous. Other means of investigating the bile ducts should be developed. If endoscopic ultrasonography and magnetic resonance cholangiography prove to have the same diagnostic value as ERCP, which must be considered the gold standard for visualizing the ducts today, they might replace ERCP as the primary investigation in patients with an intermediate or low risk of bile duct stones; this would reduce the numbers of patients exposed to the risks of ERCP.



This paper is referenced by
10.1007/s00464-012-2702-9
Management of duodeno-pancreato-biliary perforations after ERCP: outcomes from an Italian tertiary referral center
S. Alfieri (2012)
Adverse outcomes of endoscopic retrograde cholangiopancreatography.
M. Freeman (2002)
10.33915/etd.6432
Is a follow up endoscopic retrograde cholangiography procedure necessary for removal of biliary stent?
Shashank Ponugoti (2020)
10.4321/S1130-01082009001200003
Adverse events of ERCP at San José Hospital of Bogotá (Colombia).
A. Peñaloza-Ramírez (2009)
Migrated biliary stent predisposing to fatal ERCP-related perforation of the duodenum.
D. Paikos (2006)
10.1080/11024150152707752
Effect of the diameter of the common bile duct on the incidence of bile duct stones in patients with recurrent attacks of right epigastric pain after cholecystectomy.
J. Grönroos (2001)
10.1177/155335060000700406
Technical Considerations and Laparoscopic Bile Duct Exploration: Transcystic and Choledochotomy
E. Lezoche (2000)
10.1016/B978-1-4160-4271-6.50011-3
Chapter 6 – Complications of ERCP: Prediction, Prevention and Management
M. Freeman (2008)
10.3748/WJG.15.4788
Effects of contrast media on the hepato-pancreato-biliary system.
O. Topçu (2009)
Prevention of Post-ERCP Pancreatitis: Pharmacologic Solution or Patient Selection and Pancreatic Stents?
B. Bonaz (2003)
10.1089/10926420152761923
Laparoscopic common bile duct exploration.
A. Paganini (2001)
10.1155/2013/729279
Bile Duct Strictures Caused by Solid Masses: MR in Differential Diagnosis and as a Prognostic Tool to Plan the Endoscopic Treatment
T. Gorycki (2013)
10.15746/SMS.15.028
A Delayed Fatal Septic Cerebral Infarction after Endoscopic Retrograde Cholangiopancreatography
Sung Hak Lee (2015)
10.1016/J.GASTROHEP.2010.11.008
Reclamaciones por presunta negligencia relacionadas con endoscopia digestiva. Análisis de una casuística de 22 años
M. Bruguera (2011)
10.2214/AJR.176.4.1760913
Ability of MR cholangiography to reveal stent position and luminal diameter in patients with biliary endoprostheses: in vitro measurements and in vivo results in 30 patients.
E. Merkle (2001)
10.1016/B978-1-4377-0805-9.00016-9
CHAPTER 16 – EUS in Bile Duct, Gallbladder, and Ampullary Lesions
B. Napoléon (2011)
10.1007/978-3-540-68251-6_1
Pathophysiology of Acute Pancreatitis
P. Shamamian (2009)
10.1016/J.GIE.2006.03.933
Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy.
D. Verma (2007)
10.3748/WJG.V18.I34.4635
Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?
S. Tammaro (2012)
Peut-on prévoir et prévenir la pancréatite aiguë post-cholangio-pancréatographie rétrograde endoscopique ?
P. Hastier (2001)
10.1016/S1590-8658(00)80263-7
Incidence of post-endoscopic retrograde cholangiopancreatography/sphincterotomy pancreatitis depends upon definition criteria.
J. F. Riemann (2000)
10.1002/9781118769409.CH24
Adverse Events: Definitions, Avoidance, and Management
P. Cotton (2020)
Trypsin-related markers in the severity assessment of acute pancreatitis : A clinical study
M. Lempinen (2004)
10.1055/s-0029-1222562
[Magnetic resonance cholangiopancreatography (MRCP) from a radiological and gastroenterological perspective].
T. Vogl (2009)
10.1002/9781118932759.CH46
Complications of GI Endoscopy
J. Marion (2014)
10.1016/S1726-4901(09)70002-4
Effect of Somatostatin in the Prevention of Pancreatic Complications After Endoscopic Retrograde Cholangiopancreatography
Hoi-Hung Chan (2008)
Pancreatitis aguda severa temprana postcolangiopancreatografía retrógrada endoscópica, presentación de un caso
Adrián Murillo Zolezzi (2009)
10.1159/000097362
Endoscopic Retrograde Cholangiopancreatography-Induced Severe Acute Pancreatitis
S. Vege (2006)
10.4321/s1130-01082004000300001
Towards safer ERCP: selection, experience and prophylaxis.
S. Rodríguez Muñoz (2004)
10.1007/s00535-007-2013-4
Is post-endoscopic retrograde cholangiopancreatography pancreatitis the same as acute clinical pancreatitis?
Ph.D. Tetsuya Mine M.D. (2007)
10.1007/s00268-015-3076-7
Impact of Preoperative ERCP on Laparoscopic Cholecystectomy: A Case-Controlled Study with Propensity Score Matching
K. Ahn (2015)
10.1016/S0016-5085(03)00553-5
Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents?
M. Freeman (2003)
See more
Semantic Scholar Logo Some data provided by SemanticScholar